We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
(+2%)
Cap. Flow
-$91.9M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Best Buy
BBY
|
+$2.79M |
| 2 |
Bath & Body Works
BBWI
|
+$2.78M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.7M |
| 4 |
NVIDIA
NVDA
|
+$2.4M |
| 5 |
ExxonMobil
XOM
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.9M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$7.99M |
| 3 |
ORPH
Orphazyme A/S
ORPH
|
+$5.06M |
| 4 |
BridgeBio Pharma
BBIO
|
+$3.35M |
| 5 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.42% |
| 2 | Technology | 16.02% |
| 3 | Healthcare | 14.17% |
| 4 | Industrials | 13.83% |
| 5 | Financials | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Ceco Environmental
CECO
$4.14B
| $193K | 0.03% |
27,729
+1,651
| +6% | +$12.1K |
|
1002
Dare Bioscience
DARE
$21M
| $193K | 0.03% |
+12,027
| New | +$169K |
|
|
BDSI
1003
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $193K | 0.03% |
45,953
-55,022
| -54% | -$212K |
|
1004
Oaktree Specialty Lending
OCSL
$1.14B
| $191K | 0.03% |
11,404
-4,000
| -26% | -$62.1K |
|
1005
Yext
YEXT
$574M
| $191K | 0.03% |
+12,145
| New | +$208K |
|
1006
Future Fuel
FF
$223M
| $190K | 0.03% |
14,970
-32,352
| -68% | -$391K |
|
1007
Imunon
IMNN
$6.77M
| $190K | 0.03% |
1,363
+558
| +69% | +$66.9K |
|
|
CWBC
1008
Community West Bancshares
CWBC
$684M
| $188K | 0.03% |
12,594
+412
| +3% | +$5.9K |
|
|
STL
1009
DELISTED
Sterling Bancorp
STL
| $188K | 0.03% |
10,430
-21,268
| -67% | -$320K |
|
|
BNBX
1010
DELISTED
BNB PLUS CORP
BNBX
| $186K | 0.03% |
+2
| New | +$207K |
|
|
TACO
1011
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $186K | 0.03% |
20,492
-58,109
| -74% | -$503K |
|
1012
Cartesian Therapeutics
RNAC
$268M
| $185K | 0.03% |
+2,038
| New | +$177K |
|
|
ORKA
1013
Oruka Therapeutics
ORKA
$5.96B
| $185K | 0.03% |
+3,841
| New | +$191K |
|
|
MRC
1014
DELISTED
MRC Global
MRC
| $184K | 0.03% |
27,774
-21,478
| -44% | -$118K |
|
1015
Tejon Ranch
TRC
$451M
| $184K | 0.03% |
12,712
-17,177
| -57% | -$251K |
|
|
KNDI
1016
Kandi Technologies Group
KNDI
$65.5M
| $183K | 0.03% |
+26,477
| New | +$218K |
|
1017
Devon Energy
DVN
$47.3B
| $182K | 0.03% |
+11,500
| New | +$142K |
|
|
VIRX
1018
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $182K | 0.03% |
26,184
+16,825
| +180% | +$87.8K |
|
1019
Amneal Pharmaceuticals
AMRX
$5.79B
| $181K | 0.03% |
39,552
-14,312
| -27% | -$63.4K |
|
1020
Prothena Corp
PRTA
$450M
| $181K | 0.03% |
+15,095
| New | +$179K |
|
1021
Beyond Air
XAIR
$3.86M
| $180K | 0.03% |
+86
| New | +$188K |
|
1022
Research Frontiers
REFR
$17M
| $179K | 0.03% |
63,841
-3,150
| -5% | -$8.89K |
|
1023
Prospect Capital
PSEC
$1.17B
| $178K | 0.03% |
+32,958
| New | +$174K |
|
1024
Black Stone Minerals
BSM
$3B
| $176K | 0.03% |
+26,284
| New | +$178K |
|
1025
Lumen
LUMN
$6.44B
| $174K | 0.03% |
17,848
-6,271
| -26% | -$61.9K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.
GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.
- GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
- GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
- GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
- GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
- GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
- GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
- GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.
Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.